1643 — Modern Chinese Medicine Co Income Statement
0.000.00%
Last trade - 00:00- HK$468.00m
- HK$156.88m
- CNY214.07m
- 89
- 66
- 57
- 85
Annual income statement for Modern Chinese Medicine Co, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 309 | 361 | 400 | 344 | 214 |
| Cost of Revenue | |||||
| Gross Profit | 137 | 158 | 171 | 104 | 55.2 |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 218 | 246 | 275 | 276 | 199 |
| Operating Profit | 90.7 | 114 | 124 | 68.3 | 14.8 |
| Total Net Non Operating Interest Income / Expense | |||||
| Net Income Before Taxes | 90.5 | 114 | 124 | 68.3 | 14.8 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 63.6 | 81.8 | 87.8 | 48.8 | 9.67 |
| Net Income Before Extraordinary Items | |||||
| Net Income | 63.6 | 81.8 | 87.8 | 48.8 | 9.67 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 63.6 | 81.8 | 87.8 | 48.8 | 9.67 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 0.123 | 0.138 | 0.146 | 0.081 | 0.025 |
| Dividends per Share |